AAA
Affinity Asset Advisors’s NewAmsterdam Pharma NAMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.98M | Sell |
275,000
-50,000
| -15% | -$906K | 0.68% | 37 |
|
|
2025
Q1 | $6.65M | Sell |
325,000
-100,000
| -24% | -$2.05M | 0.63% | 28 |
|
|
2024
Q4 | $10.9M | Sell |
425,000
-47,390
| -10% | -$1.22M | 1.46% | 22 |
|
|
2024
Q3 | $7.84M | Buy |
472,390
+49,235
| +12% | +$817K | 1.07% | 28 |
|
|
2024
Q2 | $8.13M | Buy |
423,155
+136,955
| +48% | +$2.63M | 0.94% | 30 |
|
|
2024
Q1 | $6.77M | Buy |
286,200
+161,200
| +129% | +$3.81M | 0.84% | 31 |
|
|
2023
Q4 | $1.4M | Hold |
125,000
| – | – | 0.26% | 55 |
|
|
2023
Q3 | $1.16M | Buy |
125,000
+25,000
| +25% | +$231K | 0.33% | 45 |
|
|
2023
Q2 | $1.19M | Buy |
+100,000
| New | +$1.19M | 0.42% | 42 |
|